Cargando…

Potential Therapeutic Strategies for Skeletal Muscle Atrophy

The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people’s quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li, Li, Ming, Deng, Chunyan, Qiu, Jiayi, Wang, Kexin, Chang, Mengyuan, Zhou, Songlin, Gu, Yun, Shen, Yuntian, Wang, Wei, Huang, Ziwei, Sun, Hualin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854691/
https://www.ncbi.nlm.nih.gov/pubmed/36670909
http://dx.doi.org/10.3390/antiox12010044
_version_ 1784873184559890432
author Huang, Li
Li, Ming
Deng, Chunyan
Qiu, Jiayi
Wang, Kexin
Chang, Mengyuan
Zhou, Songlin
Gu, Yun
Shen, Yuntian
Wang, Wei
Huang, Ziwei
Sun, Hualin
author_facet Huang, Li
Li, Ming
Deng, Chunyan
Qiu, Jiayi
Wang, Kexin
Chang, Mengyuan
Zhou, Songlin
Gu, Yun
Shen, Yuntian
Wang, Wei
Huang, Ziwei
Sun, Hualin
author_sort Huang, Li
collection PubMed
description The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people’s quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle atrophy owing to an incomplete understanding of its molecular mechanisms. Exercise therapy is the most effective treatment for skeletal muscle atrophy. Unfortunately, it is not suitable for all patients, such as fractured patients and bedridden patients with nerve damage. Therefore, understanding the molecular mechanism of skeletal muscle atrophy is crucial for developing new therapies for skeletal muscle atrophy. In this review, PubMed was systematically screened for articles that appeared in the past 5 years about potential therapeutic strategies for skeletal muscle atrophy. Herein, we summarize the roles of inflammation, oxidative stress, ubiquitin-proteasome system, autophagic-lysosomal pathway, caspases, and calpains in skeletal muscle atrophy and systematically expound the potential drug targets and therapeutic progress against skeletal muscle atrophy. This review focuses on current treatments and strategies for skeletal muscle atrophy, including drug treatment (active substances of traditional Chinese medicine, chemical drugs, antioxidants, enzyme and enzyme inhibitors, hormone drugs, etc.), gene therapy, stem cell and exosome therapy (muscle-derived stem cells, non-myogenic stem cells, and exosomes), cytokine therapy, physical therapy (electroacupuncture, electrical stimulation, optogenetic technology, heat therapy, and low-level laser therapy), nutrition support (protein, essential amino acids, creatine, β-hydroxy-β-methylbutyrate, and vitamin D), and other therapies (biomaterial adjuvant therapy, intestinal microbial regulation, and oxygen supplementation). Considering many treatments have been developed for skeletal muscle atrophy, we propose a combination of proper treatments for individual needs, which may yield better treatment outcomes.
format Online
Article
Text
id pubmed-9854691
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98546912023-01-21 Potential Therapeutic Strategies for Skeletal Muscle Atrophy Huang, Li Li, Ming Deng, Chunyan Qiu, Jiayi Wang, Kexin Chang, Mengyuan Zhou, Songlin Gu, Yun Shen, Yuntian Wang, Wei Huang, Ziwei Sun, Hualin Antioxidants (Basel) Review The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people’s quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle atrophy owing to an incomplete understanding of its molecular mechanisms. Exercise therapy is the most effective treatment for skeletal muscle atrophy. Unfortunately, it is not suitable for all patients, such as fractured patients and bedridden patients with nerve damage. Therefore, understanding the molecular mechanism of skeletal muscle atrophy is crucial for developing new therapies for skeletal muscle atrophy. In this review, PubMed was systematically screened for articles that appeared in the past 5 years about potential therapeutic strategies for skeletal muscle atrophy. Herein, we summarize the roles of inflammation, oxidative stress, ubiquitin-proteasome system, autophagic-lysosomal pathway, caspases, and calpains in skeletal muscle atrophy and systematically expound the potential drug targets and therapeutic progress against skeletal muscle atrophy. This review focuses on current treatments and strategies for skeletal muscle atrophy, including drug treatment (active substances of traditional Chinese medicine, chemical drugs, antioxidants, enzyme and enzyme inhibitors, hormone drugs, etc.), gene therapy, stem cell and exosome therapy (muscle-derived stem cells, non-myogenic stem cells, and exosomes), cytokine therapy, physical therapy (electroacupuncture, electrical stimulation, optogenetic technology, heat therapy, and low-level laser therapy), nutrition support (protein, essential amino acids, creatine, β-hydroxy-β-methylbutyrate, and vitamin D), and other therapies (biomaterial adjuvant therapy, intestinal microbial regulation, and oxygen supplementation). Considering many treatments have been developed for skeletal muscle atrophy, we propose a combination of proper treatments for individual needs, which may yield better treatment outcomes. MDPI 2022-12-26 /pmc/articles/PMC9854691/ /pubmed/36670909 http://dx.doi.org/10.3390/antiox12010044 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Huang, Li
Li, Ming
Deng, Chunyan
Qiu, Jiayi
Wang, Kexin
Chang, Mengyuan
Zhou, Songlin
Gu, Yun
Shen, Yuntian
Wang, Wei
Huang, Ziwei
Sun, Hualin
Potential Therapeutic Strategies for Skeletal Muscle Atrophy
title Potential Therapeutic Strategies for Skeletal Muscle Atrophy
title_full Potential Therapeutic Strategies for Skeletal Muscle Atrophy
title_fullStr Potential Therapeutic Strategies for Skeletal Muscle Atrophy
title_full_unstemmed Potential Therapeutic Strategies for Skeletal Muscle Atrophy
title_short Potential Therapeutic Strategies for Skeletal Muscle Atrophy
title_sort potential therapeutic strategies for skeletal muscle atrophy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854691/
https://www.ncbi.nlm.nih.gov/pubmed/36670909
http://dx.doi.org/10.3390/antiox12010044
work_keys_str_mv AT huangli potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT liming potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT dengchunyan potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT qiujiayi potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT wangkexin potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT changmengyuan potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT zhousonglin potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT guyun potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT shenyuntian potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT wangwei potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT huangziwei potentialtherapeuticstrategiesforskeletalmuscleatrophy
AT sunhualin potentialtherapeuticstrategiesforskeletalmuscleatrophy